Creative Biolabs-Immuno-oncology

Anti-EphA2 (clone A14G4) SynExpress pB-Cy2-I17-E Engineered Tregs (CAT#: ITS-1124-CR378)

DatasheetDatasheet
Description
This product utilizes engineered Tregs that have been engineered with our proprietary GeneCircuit technology to specifically target EphA2 ( clone A14G4). We employs the Lentivirus (pBAD-Cy2-IL-17-EcoRI) vector components and the SynExpress system of the exons RNA Editing/Negative feedback for a robust and sustained response against cancers.
Host
Human
Target
EphA2
Clone
A14G4
Species Reactivity
Human
Cell Source
Engineered Tregs
Sensor Gene
Cy2
Promoter
pBAD
Effector Gene
IL-17
Insertion Sites
EcoRI
Gene Modification
RNA Editing
Modification Domain
Exons
Carrier Type
Lentivirus
Transformation Accuracy
0.92
Cell Culture
Adherent Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.